Prospective Identification of Subclinical Interstitial Lung Disease in a Rheumatoid Arthritis Cohort Is Associated with the MUC5B Promoter Variant

Am J Respir Crit Care Med. 2022 Feb 15;205(4):473-476. doi: 10.1164/rccm.202109-2087LE.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / genetics
  • Early Diagnosis
  • Female
  • Genetic Markers
  • Genetic Predisposition to Disease*
  • Humans
  • Lung Diseases, Interstitial / diagnosis*
  • Lung Diseases, Interstitial / epidemiology
  • Lung Diseases, Interstitial / genetics*
  • Male
  • Middle Aged
  • Mucin-5B / genetics*
  • Mutation
  • Prevalence
  • Prospective Studies

Substances

  • Genetic Markers
  • MUC5B protein, human
  • Mucin-5B